Cover Image
市場調查報告書

冠狀動脈痙攣:全球臨床實驗檢討

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 214949
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈痙攣:全球臨床實驗檢討 Coronary Vasospasm Global Clinical Trials Review, H2, 2014
出版日期: 2014年08月20日 內容資訊: 英文 57 Pages
簡介

本報告提供全球各國冠狀動脈痙攣的臨床實驗的相關調查,各地區、進展狀況、各階段、各募集情況的實驗量,代表性贊助商,正在開發的治療藥物的資訊,各企業機關的進行狀況等資訊彙整,為您概述為以下內容。

目錄

  • 目錄
  • 表格一覽
  • 圖表一覽
  • 簡介
  • 冠狀動脈痙攣
  • 報告指南
  • 臨床實驗 各地區
  • 臨床實驗 各國
  • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
  • 對臨床實驗有所貢獻的前幾名國家 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 臨床實驗 - G7 各國
  • 臨床實驗 - G7 各國 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 冠狀動脈痙攣
  • 每段時期的實驗人數
  • 有力的贊助商
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Robert Bosch Gesellschaft fur medizinische Forschung mbH
  • 臨床實驗概要; Robert Bosch Gesellschaft fur medizinische Forschung mbH
  • Robert Bosch Medical Center
  • 臨床實驗概要; Robert Bosch Medical Center
  • Kumamoto University
  • 臨床實驗概要; Kumamoto University
  • University of Nebraska
  • 臨床實驗概要; University of Nebraska
  • The University of Edinburgh
  • 臨床實驗概要; The University of Edinburgh
  • University Hospital Basel
  • 臨床實驗概要; University Hospital Basel
  • Washington University School of Medicine
  • 臨床實驗概要; Washington University School of Medicine
  • Five 主要 臨床簡介
  • 附錄
  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各地區
  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各國排名
  • 冠狀動脈痙攣 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 冠狀動脈痙攣 治療藥物的臨床實驗, 亞太地區, 前幾名國家
  • 冠狀動脈痙攣 治療藥物的臨床實驗, 歐洲, 前幾名國家
  • 冠狀動脈痙攣 治療藥物的臨床實驗, 北美, 前幾名國家
  • 冠狀動脈痙攣 治療藥物的臨床實驗, G7 各國
  • 冠狀動脈痙攣 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各階段
  • 冠狀動脈痙攣 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 冠狀動脈痙攣 全球治療藥物市場, 一時中止的臨床實驗
  • 冠狀動脈痙攣 全球治療藥物市場, 中止的臨床實驗
  • 冠狀動脈痙攣 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 冠狀動脈痙攣 全球治療藥物臨床實驗, 主要的贊助商
  • 冠狀動脈痙攣 全球治療藥物臨床實驗, 臨床實驗 - 潛力治療藥物
  • 冠狀動脈痙攣 全球治療藥物臨床實驗市場, 臨床實驗 - Robert Bosch Gesellschaft fur medizinische Forschung mbH
  • 冠狀動脈痙攣 全球治療藥物臨床實驗市場, 臨床實驗 - Robert Bosch Medical Center
  • 冠狀動脈痙攣 全球治療藥物臨床實驗市場, 臨床實驗 - Kumamoto University
  • 冠狀動脈痙攣 全球治療藥物臨床實驗市場, 臨床實驗 - University of Nebraska
  • 冠狀動脈痙攣 全球治療藥物臨床實驗市場, 臨床實驗 - The University of Edinburgh
  • 冠狀動脈痙攣 全球治療藥物臨床實驗市場, 臨床實驗 - University Hospital Basel
  • 冠狀動脈痙攣 全球治療藥物臨床實驗市場, 臨床實驗 - Washington University School of Medicine

圖表一覽

  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各國排名
  • 冠狀動脈痙攣 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 冠狀動脈痙攣 治療藥物的臨床實驗, 歐洲, 前幾名國家 (%)
  • 冠狀動脈痙攣 治療藥物的臨床實驗, G7 各國 (%)
  • 冠狀動脈痙攣 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 冠狀動脈痙攣 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 冠狀動脈痙攣 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 冠狀動脈痙攣 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 冠狀動脈痙攣 全球治療藥物臨床實驗, 主要的贊助商
  • 冠狀動脈痙攣 全球治療藥物臨床實驗, 臨床實驗 - 潛力治療藥物
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2309CTIDB

GlobalData's clinical trial report, "Coronary Vasospasm Global Clinical Trials Review, H2, 2014" provides data on the Coronary Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Coronary Vasospasm
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Coronary Vasospasm
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Coronary Vasospasm Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Japanese Coronary Spasm Association
      • Clinical Trial Overview of Japanese Coronary Spasm Association
      • Robert Bosch Medical Center
      • Clinical Trial Overview of Robert Bosch Medical Center
      • Kyorin University
      • Clinical Trial Overview of Kyorin University
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • National Institute of Health and Medical Research
      • Clinical Trial Overview of National Institute of Health and Medical Research
      • University of Nebraska
      • Clinical Trial Overview of University of Nebraska
      • Korea University
      • Clinical Trial Overview of Korea University
      • University Hospital Basel
      • Clinical Trial Overview of University Hospital Basel
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Vasospasm Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Coronary Vasospasm Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Coronary Spasm Association, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert Bosch Medical Center, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Health and Medical Research, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*

List of Figures

  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • GlobalData Methodology
Back to Top